12 June 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on six medicines.

An initial assessment report has been published for metreleptin (Myalepta) for the treatment of adults and children over two with lipodystrophy, a very rare condition in which the body is unable to maintain healthy fat tissue resulting in severe abnormalities and reduced life expectancy.

Read SMC press release